I.V. Sodium Diuril®

Print

Intravenous Sodium Diuril® (chlorothiazide sodium for injection)

As of December 22, 2011, Sodium Diuril was sold to Oak Pharmaceuticals, a subsidiary of Akorn, Inc.  For access to Akorn’s website for Sodium Diuril please click here.

Important Contact Information

You are encouraged to report negative side effects to the FDA.
Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck Inc. does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck Inc. is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck Inc.